Certificate number:RU.77.99.32.003.Е.004266.02.15
Date of registration and renewal:26.02.2015
Dosage form: & nbspTablets weighing 0.5 g.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes Supplements - vitamins, vitamin-like substances and coenzymes BAD - products of plant, animal or mineral origin Supplements - enzymes of plant or microbial origin
Classification "Clinical" & nbsp BAA sources of amino acids BAD-sources of vitamin-mineral complexes Supplements of restorative action Supplements containing zinc, copper, manganese Supplements containing iron Supplements that support the functions of the immune system Supplements antioxidants Supplements that support the function of the cardiovascular system
Composition: & nbspIngredients: autolyzed brewer's yeast "Nagypol®-C", lactose, calcium stearate or magnesium stearate, vitamin premix (vitamins E, B1, B2, B6, B12, folic acid, biotin, calcium pantothenate, nicotinamide, ascorbic acid), iron sulfate , Dietary supplements "Aspartic zinc" or zinc oxide.
Scope: & nbsp
To sell to the population through the pharmacy network and specialized shops, departments of the trade network as a biologically active food additive supplementary source of B vitamins, vitamin C and minerals (iron and zinc).
Suggested Usage: & nbsp
Adults and children over 14 years of 3-5 tablets 3 times a day with meals. Duration of admission is 30 days.
Contraindications:
Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:
Before use, it is recommended to consult a doctor.

Shelf life:
1 year.
Storage conditions:
Store in a dry place, protected from light, out of reach of children, at a temperature not exceeding 25 ° C.
Research protocols:
In exchange for the certificate of state registration No. RU.77.99.32.003.Е.001488.01.15 of 30.01.2015; expert opinion of the FGU of the Federal Target Program and the Federal Service for Supervision of Consumer Rights and Welfare No. 09-1 FC / 2347 of 18.08.05; the protocol of the Center for Analysis of the Quality of Biotechnology Products and BAD OOO BITEX №885 / 1652 of 08.12.2014.

Recipient:Bitra (Biotechnological development), LLCBitra (Biotechnological development), LLC Russia
Information update date: & nbsp08.06.2016
Instructions
Up